We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA: Orphan Drug Reports Should Include Trial Info
EMA: Orphan Drug Reports Should Include Trial Info
April 28, 2010
Orphan drug manufacturers, which must submit annual reports on product development to the European Medicines Agency (EMA), should include an overview of preclinical and clinical studies at all stages.